This is a working overview of hGH fragment, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-03-12. Anything still debated is marked as such rather than presented as settled.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
| Property | Value | Notes |
|---|---|---|
| Common name | AOD-9604 | Development code used in scientific literature. |
| Chemical class | Synthetic peptide | Fragment of human growth hormone. |
| Amino acid length | 16 residues | Matches hGH region 176-191. |
| Appearance | White to off-white powder | Typical lyophilized peptide solid. |
| Solubility | Soluble in water | Dissolves in aqueous media; exact behavior depends on salt form. |
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
In 2007, productive nanosystems were defined as functional nanoscale systems that make atomically-specified structures and devices under programmatic control, i.e., performing atomically precise manufacturing. As of 2015, such devices were only hypothetical, and productive nanosystems represented a more advanced approach among several to perform Atomically Precise Manufacturing. A workshop on Integrated Nanosystems for Atomically Precise Manufacturing was held by the Department of Energy in 2015. Present-day technologies are limited in various ways. Large atomically precise structures (that is, virtually defect-free) do not exist. Complex 3D nanoscale structures exist in the form of folded linear molecules such as DNA origami and proteins. As of 2026, it was also possible to build very small atomically precise structures using scanning probe microscopy to construct molecules such as FeCO and polyyne, or to perform hydrogen depassivation lithography. But it is not yet possible to combine components in a systematic way to build larger, more complex systems. Principles of physics and examples from nature both suggest that it will be possible to extend atomically precise fabrication to more complex products of larger size, involving a wider range of materials. An example of progress in this direction would be Christian Schafmeister's work on bis-peptides.
=== Compression === Some disorders as syndromes result from compression of a vein. These include a venous type of thoracic outlet syndrome, due to compression of a subclavian vein; nutcracker syndrome most usually due to compression of the left renal vein, and May–Thurner syndrome associated with compression of the iliac vein which can lead to iliofemoral DVT. Compression of the superior vena cava most usually by a malignant tumor can lead to superior vena cava syndrome.
Zearalenone (ZEN), also known as RAL and F-2 mycotoxin, is a potent estrogenic metabolite produced by some Fusarium and Gibberella species. Specifically, the Gibberella zeae, the fungal species where zearalenone was initially detected, in its asexual/anamorph stage is known as Fusarium graminearum. Several Fusarium species produce toxic substances of considerable concern to livestock and poultry producers, namely deoxynivalenol, T-2 toxin, HT-2 toxin, diacetoxyscirpenol (DAS) and zearalenone. Particularly, ZEN is produced by Fusarium graminearum, Fusarium culmorum, Fusarium cerealis, Fusarium equiseti, Fusarium verticillioides, and Fusarium incarnatum. Zearalenone is the primary toxin that binds to estrogen receptors, causing infertility, abortion or other breeding problems, especially in swine. Often, ZEN is detected together with deoxynivalenol in contaminated samples and its toxicity needs to be considered in combination with the presence of other toxins. Zearalenone is heat-stable and is found worldwide in a number of cereal crops, such as maize, barley, oats, wheat, rice, and sorghum. Its production increases when the climate is warm with air humidity at or above twenty percent. The environmental pH plays also a role in the toxin's production. When temperatures fall to 15 °C, alkaline soils still support ZEN production. At the preferred Fusarium temperature, which ranges between 25 °C and 30 °C, neutral pH results in the greatest toxin production.
Mamadou Diallo Sory - Former minister of Justice Maman Sambo Sidikou - former Ambassador Nigerien to the United States, United Nations secretary-general's special representative for the Democratic Republic of the Congo and head of the U.N. peacekeeping mission there, MONUSCO, high representative of the African Union for Mali and the Sahel. Abdoulaye Diori Kadidiatou Ly - jurist, former president of the Constitutional Court of Niger. Abdou Sidikou - former minister of foreign affairs, Niger. Yaou Sangaré Bakary - former ambassador to China, Minister of Foreign Affairs. Bouli Ali Diallo - academic and activist, Niger. Achta Djibrine Sy former Minister of Commerce and Industry, Chad. Banata Tchale Sow - economist, former chief of staff, Chad. Hindou Oumarou Ibrahim- environmental activist and geographer. Coordinator Association of Peul Women and Autochthonous People of Chad (AFPAT) and Co-director Pavilion of World Indigenous People, Chad Mariam Boni Diallo - first female foreign minister, Benin Republic. Ali Darassa – leader of the Central African rebel group, the Union for Peace in the Central African Republic (UPC) a self-defense force. Al-Amin Abu-Manga, linguist and professor at the University of Khartoum Ali Mohamed Issah Salou Jules Hamidou Habib Habibou Hassan Diallo
The end goal of wound care is to re-establish the integrity of the skin, a structure which serves as a barrier to the external environment. The preferred method of closure is to reattach/reapproximate the wound edges together, a process known as primary closure/healing by primary intention. Wounds that have not been closed within several hours of the initial injury or wounds that are concerning for infection will often be left open and treated with dressings for several days before being closed 3–5 days later, a process known as delayed primary closure. The exact duration of time from initial injury in which delayed primary closure is preferred over primary closure is not clearly defined. Wounds that cannot be closed primarily due to substantial tissue loss can be healed by secondary intention, a process in which the wound is allowed to fill-in over time through natural physiologic processes. When healing by secondary intention, granulation tissue grows in from the wound edges slowly over time to restore integrity of the skin. Healing by secondary intention can take up to months, requires daily wound care, and leaves an unfavorable scar, thus primary closure is always preferred when possible. As an alternative, wounds that cannot be closed primarily can be addressed with skin grafting or flap reconstruction, typically done by a plastic surgeon. There are several methods that can be implemented to achieve primary closure of a wound, including suture, staples, skin adhesive, and surgical strips. Suture is the most frequently used for closure.
Sources: en.wikipedia.org
== Plot == While working with a team from the University of Chicago on a project to convert hydrogen from water into clean energy, student machinist Eddie Kasalivich inadvertently discovers a sound frequency in his home laboratory that perfectly stabilizes their process the next day. As the team celebrates with a party at the project laboratory, Dr. Paul Shannon, the leader of the project, and Dr. Alistair Barkley, the project manager, debate whether or not to share the scientific discovery. Later that night, project physicist Dr. Lily Sinclair finds her car unable to start, so Eddie gets her home by bus. Back in the laboratory, Alistair and assistant Dr. Lu Chen prepare to upload their discovery to the Internet to share the breakthrough with the world, while a van approaches the premises. Chen hears a noise and goes outside to investigate, but is kidnapped by unknown assailants as Alistair is also attacked. Once he has dropped Lily off at Alistair's house, where she lives on the third floor, Eddie returns to the laboratory to retrieve his motorcycle but notices a suspicious van departing. Hearing alarms, he runs inside to find Alistair dead with a plastic bag over his head and Chen missing. As the hydrogen reactor has become dangerously unstable, Eddie, unable to deactivate it, speeds away as a concealed detonator triggers a massive hydrogen explosion that destroys the laboratory and eight blocks' worth of surrounding streets.
=== Philanthropy === In 1998, DiCaprio and his mother donated $35,000 for a "Leonardo DiCaprio Computer Center" at a library in Los Feliz. In May 2009, DiCaprio joined Kate Winslet, director James Cameron and Canadian singer Celine Dion, in a campaign to raise money to financially support the fees of the nursing home where Millvina Dean, a survivor of the RMS Titanic, was residing. DiCaprio and Winslet donated $20,000 to support Dean. In 2010, he donated $1 million to relief efforts in Haiti after the earthquake. In 2011, DiCaprio joined the Animal Legal Defense Fund's campaign to release Tony, a tiger that had spent the last decade at a truck stop in Grosse Tête, Louisiana. DiCaprio donated $61,000 to the gay rights group GLAAD in 2013. In 2016, DiCaprio donated $65,000 to the annual fundraising gala for the Children of Armenia Fund, where he was a special guest of his friend and honorary chair, Tony Shafrazi. Supporting Hurricane Harvey (2017) relief efforts, DiCaprio provided $1 million through his foundation. In 2020, DiCaprio's foundation donated $3 million to Australia bushfire relief efforts. Amidst the 2022 Russian invasion of Ukraine, the media announced DiCaprio donated $10 million to support Ukraine, although the news agency Associated Press suggested this amount was inaccurate.
== Visual rehabilitation and cataract surgery after RK == The PERK study demonstrated that people who undergo RK continue to drift toward hyperopia ("farsightedness"). Additionally, many of these people have reached the age where presbyopia occurs. Some also develop cataracts. Their vision can still be restored with Epi-LASIK, photorefractive keratectomy, LASIK or phakic lens extraction, or cataract surgery. The corneal curvature has to remeasured and modified by history, central keratometry, or contact lens method. Selecting intraocular lenses for cataract surgery in patients who have undergone any refractive surgery has proven challenging and is associated with decreased accuracy in lens selection. RK is associated with increased inaccuracy compared to other refractive procedures such as LASIK and PRK. This is due to difficulty measuring the corneal curvature of post-RK corneas as well as difficulty identifying an effective lens position using standard lens calculations. Additional methods have been introduced to improve the accuracy of IOL calculations. Multifocal IOL insertion in eyes that have undergone RK have not been associated with good outcomes and are generally not recommended.
However, in the middle of the night, Mundt releases Leamas and Nan from their cells and provides an escape plan for them both. Mundt explains that Leamas' real mission has succeeded; Mundt actually is a British agent, and Fiedler had been the target of the operation all along, as he had grown too suspicious of his supervisor. This comes as a shock to Leamas, and the complex web he has been drawn into and the risk he has been placed in by his own superiors become painfully clear. He explains the entire plot to still-idealistic Nan as they drive their borrowed car toward the border. She berates him for being involved in what amounts to the murder of Fiedler, who was only doing his job. Leamas, agitated by her naiveté, erupts in an angry, self-loathing confession:
During a 2019 analysis, Pew stated that they have yet to set an endpoint to Generation Z, but did use the year 2012 to complete their analysis. Jason Dorsey of the Center for Generational Kinetics also cites Pew Research's 1997–2012 range to define Gen Z in a 2025 article. In a 2022 article, U.S. Census economists Neil Bennett and Briana Sullivan described Generation Z as those born 1997 to 2013. Psychologists Jean Twenge and Jonathan Haidt argue that even though the concept of a social generation remains debated, there is evidence for significant differences between the different demographic cohorts. Those born between (on the cusp of) the Millennial generation and Generation Z are commonly known as Zillennials. Those born (on the cusp of) Generation Z and Generation Alpha are commonly known as Zalphas.
Sources: en.wikipedia.org
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.
No. It contains only a small portion of the human growth hormone sequence. The full hormone has 191 amino acids and many additional actions that the fragment does not share.
The name refers to the amino acid positions in the human growth hormone chain. The fragment spans residues 176 through 191 at the C-terminal end. This naming convention helps distinguish it from full-length hGH.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.